Location History:
- Lakewood, CO (US) (1986 - 1990)
- Phoenix, AZ (US) (1990)
- Littleton, CO (US) (2001)
- Downingtown, PA (US) (2010 - 2015)
Company Filing History:
5 out of 160 
3 out of 80 
1 out of 20,290 
Years Active: 1986-2015
Title: Scott Jenkins: Innovator in Nanoparticulate Compositions
Introduction
Scott Jenkins is a notable inventor based in Downingtown, PA (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 14 patents. His work primarily focuses on improving the bioavailability and efficacy of various drug compositions.
Latest Patents
Among his latest patents are the nanoparticulate cinacalcet compositions. These compositions consist of stable nanoparticulate cinacalcet or a salt thereof, showcasing an improved dissolution rate and enhanced bioavailability. They also demonstrate a reduced difference in absorption when administered orally under fed conditions compared to fasting conditions. Another significant invention is the nanoparticulate carvedilol formulations. This invention is directed towards nanoparticulate carvedilol compositions that exhibit improved pharmacokinetic profiles, bioavailability, dissolution rates, and overall efficacy. Notably, the effective average particle size of these compositions is less than about 2000 nm.
Career Highlights
Scott Jenkins has worked with various companies throughout his career, including Alkermes Pharma Ireland Limited. His innovative work in the pharmaceutical industry has led to advancements in drug delivery systems and formulations.
Collaborations
Throughout his career, Scott has collaborated with notable individuals such as Gary G. Liversidge and Craig D. Jenkins. These collaborations have contributed to the development of his patented technologies and innovations.
Conclusion
Scott Jenkins is a prominent inventor whose work in nanoparticulate compositions has significantly impacted the pharmaceutical industry. His contributions continue to enhance drug formulations and improve patient outcomes.